Abstract:Abstract Motivation Understanding the intermolecular interactions of ligand–target pairs is key to guiding the optimization of drug research on cancers, which can greatly mitigate overburden workloads for wet labs. Several improved computational methods have been introduced and exhibit promising performance for these identification tasks, but some pitfalls restrict their practical applications: (i) first, existing methods do not sufficiently consider how multigranular molecule representations influence interaction patterns between proteins and compounds; and (ii) second, existing methods seldom explicitly model the binding sites when an interaction occurs to enable better prediction and interpretation, which may lead to unexpected obstacles to biological researchers. Results To address these issues, we here present DrugMGR, a deep multigranular drug representation model capable of predicting binding affinities and regions for each ligand–target pair. We conduct consistent experiments on three benchmark datasets using existing methods and introduce a new specific dataset to better validate the prediction of binding sites. For practical application, target-specific compound identification tasks are also carried out to validate the capability of real-world compound screen. Moreover, the visualization of some practical interaction scenarios provides interpretable insights from the results of the predictions. The proposed DrugMGR achieves excellent overall performance in these datasets, exhibiting its advantages and merits against state-of-the-art methods. Thus, the downstream task of DrugMGR can be fine-tuned for identifying the potential compounds that target proteins for clinical treatment. Availability and implementation https://github.com/lixiaokun2020/DrugMGR.

Measuring Ligand‐bound Protein Complexes with Proximity Labeling: A Practical Guide.

Methods to Profile the Macromolecular Targets of Small Compounds.

Identifying The Proteins To Which Small-Molecule Probes And Drugs Bind In Cells

Label-free target protein characterization for small molecule drugs: recent advances in methods and applications

Identifying cellular targets of small-molecule probes and drugs with biochemical enrichment and SILAC.

Chemical Proteomics to Identify Molecular Targets of Small Compounds

A Proximity Based General Method for Identification of Ligand and Receptor Interactions in Living Cells.

Proximity Biosensor Assay for PROTAC Ternary Complex Analysis

Chemical Proteomics-based Target Prioritization through a Residue Agnostic Ligandability Assessment Platform

Proximity-based labelling for proteomic mapping

Identifying the Cellular Targets of Bioactive Small Molecules with Activity-Based Probes.

Protein-ligand binding site detection as an alternative route to molecular docking and drug repurposing

μMap Photoproximity Labeling Enables Small Molecule Binding Site Mapping

Recent advances and method development for drug target identification

Chemical-Protein Interactome and Its Application in Off-Target Identification

A computational method for detection of ligand-binding proteins from dose range thermal proteome profiles

Chemical proteomic mapping of reversible small molecule binding sites in native systems

Small Bioactive Molecules Designed to Be Probes As Baits "fishing Out" Cellular Targets: Finding the Fish in the Proteome Sea

DrugMGR: a deep bioactive molecule binding method to identify compounds targeting proteins

Chemical Proteomics: Terra Incognita for Novel Drug Target Profiling

Proteomic methods for drug target discovery